Purification of a functional competitive antagonist for calcitonin gene related peptide action from sardine hydrolysates
Full Text
Reprint PDF

Keywords

biological activity
cyclic AMP
peptone
radioimmunoassay
radioreceptorassay

How to Cite

1.
Rousseau M, Batista I, Le Gal Y, Fouchereau-Peron M. Purification of a functional competitive antagonist for calcitonin gene related peptide action from sardine hydrolysates. Electron. J. Biotechnol. [Internet]. 2001 Apr. 15 [cited 2024 Sep. 20];4(1):0-. Available from: https://preprints.pucv.cl/index.php/ejbiotechnology/article/view/v4n1-3

Abstract

Calcitonin gene related peptide (CGRP) related molecules were purified from sardine hydrolysates prepared using 0.1% alcalase and two hours of hydrolysis. Gel exclusion chromatography and HPLC performed purification of these molecules. The purified molecules were characterised using specific CGRP radioimmunoassays and radioreceptoraasays. From 22 mg of crude extract, we obtained 14 µg of CGRP related molecules, the molecular weight determined by mass spectrophotometry was 6000 daltons. The biological activity of these molecules was analysed using the ability of CGRP to stimulate the adenylate cyclase activity in rat liver membranes. The purified molecules induced an inhibition of the CGRP stimulated adenylate cyclase activity, this effect was specific as no such effect was observed on the glucagon stimulated adenylate cyclase activity measured in the same rat liver membrane preparation. These results suggest that the purified molecules may act as antagonists for peptides that bind to CGRP receptors in rat liver membranes. These new antagonists may be of particular importance in various aspects of CGRP action in vertebrates.

Full Text
Reprint PDF

Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".

The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.